Here, we found that Schizandrin C reduced the phosphorylation of p38 MAPK and ERK, suggesting that Schizandrin C attenuates liver fibrosis, regulates lipid metabolism, inhibits inflammation response and NF-κB activity was associated with the p38/ERK MAPK signaling pathway. This evidence concerns the gene NFKB1 and Hepatic fibrosis.